title: BMP-6 is an autocrine stimulator of chondrocyte differentiation.
abstract: While parathyroid hormone-related protein (PTHrP) has been characterized as an important negative regulator of chondrocyte maturation in the growth plate, the autocrine or paracrine factors that stimulate chondrocyte maturation are not well characterized. Cephalic sternal chondrocytes were isolated from 13-day embryos, and the role of bone morphogenetic protein-6 (BMP-6) as a positive regulator of chondrocyte maturation was examined in monolayer cultures. Progressive maturation, which was accelerated in the presence of ascorbate, occurred in the cultures. During maturation, the cultures expressed high levels of BMP-6 mRNA which preceded the induction of type X collagen mRNA. Treatment of the cultures with PTHrP (10(-7) M) at the time of plating completely abolished BMP-6 and type X collagen mRNA expression. Removal of PTHrP after 6 days was followed by the rapid (within 24 h) expression of BMP-6 and type X collagen mRNA, with BMP-6 again preceding type X collagen expression. The addition of exogenous BMP-6 (100 ng/ml) to the cultures accelerated the maturation process both in the presence and absence of ascorbate and resulted in the highest levels of type X collagen. When exogenous BMP-6 was added to PTHrP containing cultures, maturation occurred with the expression of high levels of type X collagen, despite the presence of PTHrP in the cultures. Furthermore, BMP-6 did not stimulate expression of its own mRNA in the PTHrP treated cultures, but it did stimulate the expression of Indian hedgehog (Ihh) mRNA. These latter findings suggest that while PTHrP directly inhibits BMP-6, it indirectly regulates Ihh expression through BMP-6. Other phenotypic changes associated with chondrocyte differentiation were also stimulated by BMP-6, including increased alkaline phosphatase activity and decreased proliferation. The results suggest that BMP-6 is an autocrine factor that initiates chondrocyte maturation and that PTHrP may prevent maturation by inhibiting the expression of BMP-6.
authors.affiliation: Department of Orthopaedics, University of Rochester School of Medicine and Dentistry, New York, USA.
authors.forename: C D
authors.initials: CD
authors.lastname: Grimsrud
authors.forename: P R
authors.initials: PR
authors.lastname: Romano
authors.forename: M
authors.initials: M
authors.lastname: D'Souza
authors.forename: J E
authors.initials: JE
authors.lastname: Puzas
authors.forename: P R
authors.initials: PR
authors.lastname: Reynolds
authors.forename: R N
authors.initials: RN
authors.lastname: Rosier
authors.forename: R J
authors.initials: RJ
authors.lastname: O'Keefe
mesh_terms: D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D055418:Bone Morphogenetic Protein 6; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D002478:Cells, Cultured; D002642:Chick Embryo; D019902:Chondrocytes / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D003094:Collagen / Q000235:genetics; D015870:Gene Expression / Q000187:drug effects; D008954:Models, Biological; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism
chemical_list: D055418:Bone Morphogenetic Protein 6; D019485:Bone Morphogenetic Proteins; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins; D012333:RNA, Messenger; D003094:Collagen; D000469:Alkaline Phosphatase; D001205:Ascorbic Acid; D013936:Thymidine